{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:03:02Z","timestamp":1784192582448,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0531100"],"award-info":[{"award-number":["2024ZD0531100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00216-026-06552-9","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:21:50Z","timestamp":1779157310000},"page":"4561-4573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial lipidomics with in situ segmentation for profiling doxorubicin drug effect of hepatoma carcinoma cell spheroids"],"prefix":"10.1007","volume":"418","author":[{"given":"Xiunan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luheng","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"3","key":"6552_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"6552_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01424-y","volume":"9","author":"H Zhao","year":"2023","unstructured":"Zhao H, Wei S, Zhou D, Liu Y, Guo Z, Fang C, et al. Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodelling the tumour microenvironment via the NF-\u03baB\/IL-1\u03b2\/CXCL1 signalling pathway. Cell Death Discov. 2023;9(1):120.","journal-title":"Cell Death Discov"},{"issue":"6","key":"6552_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10334-005-0013-z","volume":"18","author":"J Alvarez-P\u00e9rez","year":"2005","unstructured":"Alvarez-P\u00e9rez J, Ballesteros P, Cerd\u00e1n S. Microscopic images of intraspheroidal pH by 1H magnetic resonance chemical shift imaging of pH sensitive indicators. Magn Reson Mater Phys Biol Med. 2005;18(6):293\u2013301.","journal-title":"Magn Reson Mater Phys Biol Med"},{"issue":"3","key":"6552_CR4","first-page":"1116","volume":"12","author":"E Jouberton","year":"2022","unstructured":"Jouberton E, Voissiere A, Penault-Llorca F, Cachin F, Miot-Noirault E. Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drugs. Am J Cancer Res. 2022;12(3):1116\u201328.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"6552_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02791-5","volume":"25","author":"P Hulo","year":"2024","unstructured":"Hulo P, Deshayes S, Fresquet J, Ch\u00e9n\u00e9 AL, Blandin S, Boisgerault N, et al. Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy. Respir Res. 2024;25(1):156.","journal-title":"Respir Res"},{"issue":"1","key":"6552_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68665-4","volume":"14","author":"H Dabiri","year":"2024","unstructured":"Dabiri H, Mortezaei Z. Genome-wide association study of therapeutic response to statin drugs in cardiovascular disease. Sci Rep. 2024;14(1):18005.","journal-title":"Sci Rep"},{"issue":"1","key":"6552_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26951-z","volume":"12","author":"SM Tirier","year":"2021","unstructured":"Tirier SM, Mallm JP, Steiger S, Poos AM, Awwad MHS, Giesen N, et al. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics. Nat Commun. 2021;12(1):6960.","journal-title":"Nat Commun"},{"issue":"6","key":"6552_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-022-01539-0","volume":"41","author":"DC Mitchell","year":"2023","unstructured":"Mitchell DC, Kuljanin M, Li J, Van Vranken JG, Bulloch N, Schweppe DK, et al. A proteome-wide atlas of drug mechanism of action. Nat Biotechnol. 2023;41(6):845\u201357.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"6552_CR9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201606","volume":"218","author":"X Bian","year":"2021","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218(1):e20201606.","journal-title":"J Exp Med"},{"issue":"11","key":"6552_CR10","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34(11):1675\u201399.","journal-title":"Cell Metab"},{"issue":"3","key":"6552_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.trecan.2025.11.012","volume":"12","author":"J Rupert","year":"2026","unstructured":"Rupert J, Cao PHA, Frigo DE, Kolonin MG. Lipids grease the chain of cancer progression. Trends Cancer. 2026;12(3):235\u201347.","journal-title":"Trends Cancer"},{"issue":"2","key":"6552_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11427-024-2968-1","volume":"69","author":"Z Qi","year":"2026","unstructured":"Qi Z, Kong X, Wu J, Du X, Jiang M, Yu Z, et al. Disulfiram-induced c-FOS influences lipid metabolism and angiogenesis in hepatocellular carcinoma. Science China Life Sciences. 2026;69(2):455\u201372.","journal-title":"Science China Life Sciences"},{"issue":"6","key":"6552_CR13","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1021\/acs.jproteome.0c00038","volume":"19","author":"R Eghlimi","year":"2020","unstructured":"Eghlimi R, Shi X, Hrovat J, Xi B, Gu H. Triple negative breast cancer detection using LC-MS\/MS lipidomic profiling. J Proteome Res. 2020;19(6):2367\u201378.","journal-title":"J Proteome Res"},{"issue":"1","key":"6552_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1021\/acs.analchem.0c04414","volume":"93","author":"AS Edison","year":"2021","unstructured":"Edison AS, Colonna M, Gouveia GJ, Holderman NR, Judge MT, Shen X, et al. NMR: unique strengths that enhance modern metabolomics research. Anal Chem. 2021;93(1):478\u201399.","journal-title":"Anal Chem"},{"issue":"19","key":"6552_CR15","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1021\/acs.analchem.0c02519","volume":"92","author":"X Yan","year":"2020","unstructured":"Yan X, Zhao X, Zhou Z, McKay A, Brunet A, Zare RN. Cell-type-specific metabolic profiling achieved by combining desorption electrospray ionization mass spectrometry imaging and immunofluorescence staining. Anal Chem. 2020;92(19):13281\u20139.","journal-title":"Anal Chem"},{"key":"6552_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2022.116809","volume":"157","author":"H Liu","year":"2022","unstructured":"Liu H, Pan Y, Xiong C, Han J, Wang X, Chen J, et al. Matrix-assisted laser desorption\/ionization mass spectrometry imaging (MALDI MSI) for in situ analysis of endogenous small molecules in biological samples. TrAC Trends in Analytical Chemistry. 2022;157:116809.","journal-title":"TrAC Trends in Analytical Chemistry"},{"issue":"23","key":"6552_CR17","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.1039\/D1SC00271F","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Wang Z, Liu L, Zhu J, Zhang D, Xu M, et al. Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine. Chem Sci. 2021;12(23):7993\u20138009.","journal-title":"Chem Sci"},{"issue":"9","key":"6552_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100599","volume":"65","author":"P Seubnooch","year":"2024","unstructured":"Seubnooch P, Montani M, Dufour JF, Masoodi M. Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in metabolic dysfunction-associated steatohepatitis. J Lipid Res. 2024;65(9):100599.","journal-title":"J Lipid Res"},{"issue":"29","key":"6552_CR19","doi-asserted-by":"publisher","first-page":"10542","DOI":"10.1021\/acs.est.3c01746","volume":"57","author":"J Chen","year":"2023","unstructured":"Chen J, Xie P, Wu P, Lin Z, He Y, Cai Z. Spatial metabolomics and lipidomics reveal the mechanisms of the enhanced growth of breast cancer cell spheroids exposed to triclosan. Environ Sci Technol. 2023;57(29):10542\u201353.","journal-title":"Environ Sci Technol"},{"issue":"1","key":"6552_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.125306","volume":"268","author":"H Liu","year":"2024","unstructured":"Liu H, Xie T, Wang J, Wang X, Han J, Huang Z, et al. In situ analysis of metabolic changes under hypoxic-ischemic encephalopathy via MALDI mass spectrometry imaging. Talanta. 2024;268(1):125306.","journal-title":"Talanta"},{"key":"6552_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2021.338342","volume":"1155","author":"Q Zang","year":"2021","unstructured":"Zang Q, Sun C, Chu X, Li L, Gan W, Zhao Z, et al. Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures. Anal Chim Acta. 2021;1155:338342.","journal-title":"Anal Chim Acta"},{"issue":"1","key":"6552_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-4-12","volume":"4","author":"D Khaitan","year":"2006","unstructured":"Khaitan D, Chandna S, Arya MB, Dwarakanath BS. Establishment and characterization of multicellular spheroids from a human glioma cell line; implications for tumor therapy. J Transl Med. 2006;4(1):12.","journal-title":"J Transl Med"},{"key":"6552_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111536","volume":"138","author":"M Nowacka","year":"2021","unstructured":"Nowacka M, Sterzynska K, Andrzejewska M, Nowicki M, Januchowski R. Drug resistance evaluation in novel 3D in vitro model. Biomed Pharmacother. 2021;138:111536.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"6552_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000367754","volume":"5","author":"LC Lu","year":"2016","unstructured":"Lu LC, Hsu CH, Hsu C, Cheng AL. Tumor heterogeneity in hepatocellular carcinoma: facing the challenges. Liver Cancer. 2016;5(2):128\u201338.","journal-title":"Liver Cancer"},{"issue":"1","key":"6552_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","volume":"8","author":"M Alves-Bezerra","year":"2017","unstructured":"Alves-Bezerra M, Cohen DE. Triglyceride metabolism in the liver. Compr Physiol. 2017;8(1):1\u20138.","journal-title":"Compr Physiol"},{"issue":"2\u20133","key":"6552_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1388-1981(02)00328-1","volume":"1585","author":"Z Cui","year":"2002","unstructured":"Cui Z, Houweling M. Phosphatidylcholine and cell death. Biochim Biophys Acta. 2002;1585(2\u20133):87\u201396.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"6552_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10050186","volume":"10","author":"Z Pang","year":"2020","unstructured":"Pang Z, Chong J, Li S, Xia J. MetaboAnalystR 3.0: toward an optimized workflow for global metabolomics. Metabolites. 2020;10(5):186.","journal-title":"Metabolites"},{"issue":"1","key":"6552_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"A Nunes","year":"2019","unstructured":"Nunes A, Barros A, Costa E, Moreira A, Correia I. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol Bioeng. 2019;116(1):206\u201326.","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"6552_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","volume":"164","author":"G Mehta","year":"2012","unstructured":"Mehta G, Hsiao A, Ingram M, Luker G, Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release. 2012;164(2):192\u2013204.","journal-title":"J Control Release"},{"key":"6552_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.semcancer.2023.11.008","volume":"97","author":"R Abou Khouzam","year":"2023","unstructured":"Abou Khouzam R, Janji B, Thiery J, Zaarour RF, Chamseddine AN, Mayr H, et al. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: impact on cancer immunotherapy. Semin Cancer Biol. 2023;97:104\u201323.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"6552_CR31","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s12094-023-03380-6","volume":"26","author":"S Sritharan","year":"2024","unstructured":"Sritharan S, Sivalingam N. Doxorubicin-induced chemoresistance in Duke\u2019s type B colon adenocarcinoma cell line is aggravated in the presence of TGF-\u03b22 through non-apoptotic cell death. Clin Transl Oncol. 2024;26(7):1630\u20138.","journal-title":"Clin Transl Oncol"},{"key":"6552_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.807636","volume":"11","author":"M Bataller","year":"2021","unstructured":"Bataller M, S\u00e1nchez-Garc\u00eda A, Garcia-Mayea Y, Mir C, Rodriguez I, Me LL. The role of sphingolipids metabolism in cancer drug resistance. Front Oncol. 2021;11:807636.","journal-title":"Front Oncol"},{"issue":"19","key":"6552_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911178","volume":"23","author":"P Pal","year":"2022","unstructured":"Pal P, Atilla-Gokcumen GE, Frasor J. Emerging roles of ceramides in breast cancer biology and therapy. Int J Mol Sci. 2022;23(19):807636.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6552_CR34","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.bbrc.2005.02.188","volume":"330","author":"W Cao","year":"2005","unstructured":"Cao W, Chi WH, Wang J, Tang JJ, Lu YJ. TNF-alpha promotes doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells. Biochem Biophys Res Commun. 2005;330(4):1034\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"6552_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1506971","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Li G. Editorial: The role of sphingolipid metabolism in endocrine diseases. Front Endocrinol. 2024;15:1506971.","journal-title":"Front Endocrinol"},{"issue":"1","key":"6552_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4829180","volume":"2017","author":"D Patel","year":"2017","unstructured":"Patel D, Witt SN. Ethanolamine and phosphatidylethanolamine: partners in health and disease. Oxid Med Cell Longev. 2017;2017(1):4829180.","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"6552_CR37","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41419-018-1194-5","volume":"9","author":"P Liang","year":"2018","unstructured":"Liang P, Jiang B, Li Y, Liu Z, Zhang P, Zhang M, et al. Autophagy promotes angiogenesis via AMPK\/Akt\/mTOR signaling during the recovery of heat-denatured endothelial cells. Cell Death Dis. 2018;9(12):1152.","journal-title":"Cell Death Dis"},{"issue":"3","key":"6552_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.plipres.2011.02.004","volume":"50","author":"M Hermansson","year":"2011","unstructured":"Hermansson M, Hokynar K, Somerharju P. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog Lipid Res. 2011;50(3):240\u201357.","journal-title":"Prog Lipid Res"},{"issue":"10","key":"6552_CR39","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/ejlt.200700024","volume":"109","author":"JP Slotte","year":"2007","unstructured":"Slotte JP, Ramstedt B. The functional role of sphingomyelin in cell membranes. Eur J Lipid Sci Technol. 2007;109(10):977\u201381.","journal-title":"Eur J Lipid Sci Technol"},{"issue":"4","key":"6552_CR40","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.plipres.2013.05.001","volume":"52","author":"JP Slotte","year":"2013","unstructured":"Slotte JP. Biological functions of sphingomyelins. Prog Lipid Res. 2013;52(4):424\u201337.","journal-title":"Prog Lipid Res"},{"issue":"5","key":"6552_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050850","volume":"16","author":"H Nojima","year":"2024","unstructured":"Nojima H, Shimizu H, Murakami T, Shuto K, Koda K. Critical roles of the sphingolipid metabolic pathway in liver regeneration, hepatocellular carcinoma progression and therapy. Cancers. 2024;16(5):850.","journal-title":"Cancers"},{"issue":"20","key":"6552_CR42","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.7150\/thno.45125","volume":"10","author":"W Chang","year":"2020","unstructured":"Chang W, Fa H, Xiao D, Wang J. Targeting phosphatidylserine for cancer therapy: prospects and challenges. Theranostics. 2020;10(20):9214\u201329.","journal-title":"Theranostics"},{"issue":"10","key":"6552_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105297","volume":"22","author":"EM Haberl","year":"2021","unstructured":"Haberl EM, Weiss TS, Peschel G, Weigand K, K\u00f6hler N, Pauling JK, et al. Liver lipids of patients with hepatitis B and C and associated hepatocellular carcinoma. Int J Mol Sci. 2021;22(10):5297.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6552_CR44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/biom3030481","volume":"3","author":"PM Tamashiro","year":"2013","unstructured":"Tamashiro PM, Furuya H, Shimizu Y, Iino K, Kawamori T. The impact of sphingosine kinase-1 in head and neck cancer. Biomolecules. 2013;3(3):481\u2013513.","journal-title":"Biomolecules"},{"issue":"9","key":"6552_CR45","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1158\/0008-5472.CAN-05-3410","volume":"66","author":"LP Swift","year":"2006","unstructured":"Swift LP, Rephaeli A, Nudelman A, Phillips DR, Cutts SM. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death. Cancer Res. 2006;66(9):4863\u201371.","journal-title":"Cancer Res"},{"key":"6552_CR46","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2147\/JHC.S474010","volume":"11","author":"H Powell","year":"2024","unstructured":"Powell H, Coarfa C, Ruiz-Echartea E, Grimm SL, Najjar O, Yu B, et al. Differences in prediagnostic serum metabolomic and lipidomic profiles between cirrhosis patients with and without incident hepatocellular carcinoma. J Hepatocell Carcinoma. 2024;11:1699\u2013712.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"6552_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40001-022-00854-1","volume":"27","author":"L Li","year":"2022","unstructured":"Li L, Wang X, Ding Y, Hui N, Su B, Yang M. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Eur J Med Res. 2022;27(1):216.","journal-title":"Eur J Med Res"},{"key":"6552_CR48","doi-asserted-by":"publisher","first-page":"9117","DOI":"10.2147\/IJGM.S344723","volume":"14","author":"T Lin","year":"2021","unstructured":"Lin T, Zhang E, Lin Z, Peng L. Comprehensive analysis of LPCATs highlights the prognostic and immunological values of LPCAT1\/4 in hepatocellular carcinoma. Int J Gen Med. 2021;14:9117\u201330.","journal-title":"Int J Gen Med"},{"issue":"2","key":"6552_CR49","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/ijms22020726","volume":"22","author":"M Codini","year":"2021","unstructured":"Codini M, Garcia-Gil M, Albi E. Cholesterol and sphingolipid enriched lipid rafts as therapeutic targets in cancer. Int J Mol Sci. 2021;22(2):726.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"6552_CR50","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/14737159.2023.2254884","volume":"23","author":"K Li","year":"2023","unstructured":"Li K, Shi W, Song Y, Qin L, Zang C, Mei T, et al. Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction. Expert Rev Mol Diagn. 2023;23(11):1015\u201326.","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-026-06552-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:03:27Z","timestamp":1784189007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-026-06552-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":50,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6552"],"URL":"https:\/\/doi.org\/10.1007\/s00216-026-06552-9","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}